Preparing for Possible Drug Pricing Changes
The COVID-19 pandemic that has pushed the U.S. healthcare system to its limits and crippled the economy has brought stark attention to the need for new legislation to lower medication prices.
COVID-19 Business Recovery
Life during the COVID-19 pandemic is surreal even after a year. Healthcare organizations are being pressured to do more with less while at the same time contribute revenue to whittle away at staggering losses.
Proposed Payment Rules and Court Rulings
Two court rulings and segments of the proposed OPPS/ASC and PFS rules may require action from providers to recover expenses caused by the COVID-19 pandemic.
Data Integrity Vigilance: Telling Patient Pandemic Stories
While focusing on being prepared, safe and innovative during the COVID-19 pandemic, healthcare providers mustn’t overlook the critical importance of data integrity.
CMS Price Transparency: The Basics
The Centers for Medicare and Medicaid Services (CMS) released its final rule requiring hospitals to disclose payer-specific negotiated rates effective Jan. 1, 2021. Becoming familiar with the rule’s definitions will assist in making necessary changes to be compliant.
Short-Dated Products: Reducing Unsalable Returns and Supply Chain Waste
The glut of soon-to-expire products within the pharmaceutical supply chain is a costly problem impacting multiple stakeholders, but smart technology and innovative inventory management systems offer cost-saving solutions.
Complying with Rules Ensures Reimbursement for Drugs
Healthcare costs continue to rise and payment models subsequently evolve, payers nevertheless largely decide which expensive high-investment drugs will be reimbursed and under what circumstances.
CMS 2020 Proposed and Final OPPS and ASC Rules
New CMS rules focus on transparency to reduce cost in a patient-driven healthcare system.
Approaching New Payment Rules
How CMS reimbursement rules directly impact community hospitals and what payers are doing in response.
Impacts of the Opioid Crisis Response Act
The final version of the Opioid Crisis Response Act (H.R. 6) has been signed into law to address the nationwide opioid crisis by expanding and creating programs for prevention, treatment and recovery.